Sorrento Therapeutics, Inc. Soared
Mon 10 Aug 20 at 05:34 PM
Sorrento Therapeutics, Inc. (SRNE:NASDAQ) soared at $18.82, representing a gain of 30.5%. On Fri 07 Aug 20, SRNE:NASDAQ hit a New 2-Week High of $14.42. The stock got featured on our News Catalysts scanner on Sun 09 Aug 20 at 12:13 PM in the 'MISCELLANEOUS' category. From Fri 24 Jul 20, the stock recorded 80.00% Up Days and 54.55% Green Days
About Sorrento Therapeutics, Inc. (SRNE:NASDAQ)
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.
Top 10 Gainers:
- Seres Therapeutics, Inc. (MCRB:NASDAQ), 389.22%
- Omeros Corporation (OMER:NASDAQ), 50.88%
- BiomX Inc. (PHGE:NYSEMKT), 42.1%
- Commercial Vehicle Group, Inc. (CVGI:NASDAQ), 37.04%
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 32.43%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 31.75%
- Trevena, Inc. (TRVN:NASDAQ), 31.51%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 30.51%
- LSB Industries, Inc. (LXU:NYSE), 29.75%
- Ocugen, Inc. (OCGN:NASDAQ), 28.18%